MAC 3™ Resting ECG Machine - ECG Equipment

Save 10% on framework price of the GE HealthCare MAC 3™ Resting ECG Machine and receive a free carry case.

The MAC 3™ is a resting electrocardiograph (ECG) system built for fast, confident ECG acquisition in community settings. It provides a reliable diagnostic trace without lengthy set-up. A touchscreen interface with hot keys makes operation intuitive, including for first-time and rotating staff. The unit can operate with Wi-Fi enabling unidirectional transmission to the MUSE™ Cardiology Information System enabling secure transmission for a second opinion when time matters, supporting quicker clinical decisions.

ECG data can also be downloaded to storage medium via USB. Its lightweight, durable design travels easily between care areas, and the cables, leadwires and accessories are easy to clean and withstand repeated bending and twisting, supporting both patient comfort and a long service life. Under this Special Offer

Capital Saving, NHS organisations receive a 10% saving against the framework price of the MAC 3 Resting ECG System, together with a carry case included at no additional charge.

• Designed for community-based care.
• Lightweight, durable construction travels easily between sites.
• Touchscreen interface with hot keys supports intuitive use by first-time and rotating staff.
• 12SL Algorhythm for adults and paediatrics.
• Hookup advisor and lead reversal detection.
• Storage 200 x 12 Lead ECG recordings.
• Built-in Wi-Fi and unidirection interface with MUSE™.
• USB compliant flash drive for external storage.
• Cables, leadwires and accessories are easy to clean and withstand bending and twisting.
• Battery capacity 120 x 12 Lead ECGs.
• Strict testing supports quality, reliability and safety in routine use.
• Carry case included at no additional charge during the promotional period.

This offer is over and above the standard discount available through the NHS Supply Chain framework agreement. The discount is a fixed term offer. All orders must be placed before 31 March 2027.